By Bachem AG
To get in touch with Bachem AG, simply fill out the form below.
Subscribe to Supplier
Bachem to present oligo purification advances at IOPC Milan
Bubendorf, Switzerland: –Peptide and Oligonucleotide technology specialist Bachem AG will be a high profile presence at the third International Oligonucleotide and Peptide Conference, IOPC 2022, in Milan, Italy.
Bachem will again be a Gold Sponsor, exhibitor and scientific contributor at the event in late June.
Continuous Chromatography Purification
The IOPC conference program will feature a presentation on ‘Purification of Synthetic Oligonucleotides Using Continuous Chromatography (MCSGP)’, presented by Bachem Process Manager for Chromatography and Technology Transfer Oligo, Dr. Ralf Eisenhuth (June 28, Oligonucleotides Session, 1500-1520 hrs).
The Bachem exhibition stand at Booth 2 will display the company’s extensive portfolio of tides development and cGMP manufacturing capabilities, with Oligonucleotides Business Development Manager Claudia Murar and Peptides Business Development Managers Christophe Chambard and Georgios Georgopoulus on hand to answer visitor queries.
The Bachem Team will also be present on the event’s networking tables to explore partnership opportunities.
Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides.
With over 50 years of experience and expertise Bachem provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services.
Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange.
For further information, see www.bachem.com.
About IOPC 2022
First staged in 2019, the International Oligonucleotides and Peptides Conference (IOPC) was founded to provide a specialized annual knowledge sharing platform for Tides-based therapeutics.
The conference aims to help development and production practitioners optimize their oligonucleotide and peptide therapeutics value chains by following best practices and sharing case studies.
IOPC 2022 is a three-day event opening June 27 at the Grand Visconti Palace, Milano.
One of the parallel scientific tracks will focus on Peptides, highlighting manufacturing upstream, purification, drug discovery, alternative applications, drug delivery and formulation, and materials. The other track will be devoted to Oligonucleotides, focusing on chemical diversity and synthetic issues, delivery and formulation, preclinical studies, and clinical updates.
The event is organized by Tekno Scienze Srl, with further information at: https://www.iopc-tks.com/